Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,514 | 419 | 97.7% |
| Education | $175.00 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,042 | 64 | $0 (2024) |
| ABBVIE INC. | $789.23 | 51 | $0 (2024) |
| Amgen Inc. | $666.53 | 35 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $653.23 | 29 | $0 (2023) |
| Lilly USA, LLC | $608.84 | 39 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $577.28 | 28 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $568.41 | 32 | $0 (2024) |
| GlaxoSmithKline, LLC. | $394.38 | 28 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $354.30 | 20 | $0 (2024) |
| PFIZER INC. | $314.96 | 19 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $919.94 | 50 | ABBVIE INC. ($171.80) |
| 2023 | $2,208 | 107 | ABBVIE INC. ($423.07) |
| 2022 | $2,334 | 126 | Novo Nordisk Inc ($372.71) |
| 2021 | $2,226 | 138 | Novo Nordisk Inc ($327.77) |
All Payment Transactions
421 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Oncology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Inflammation | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/10/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $90.00 | General |
| 06/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: Cardio-renal | ||||||
| 06/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Bone Health | ||||||
| 05/21/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Neurology | ||||||
| 05/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Respiratory | ||||||
| 04/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 105 | 133 | $10,543 | $4,684 |
| 2022 | 3 | 96 | 115 | $7,910 | $3,329 |
| 2021 | 2 | 69 | 74 | $5,750 | $3,236 |
| 2020 | 2 | 55 | 55 | $4,050 | $1,371 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 54 | $7,145 | $2,517 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $2,700 | $1,654 | 61.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 48 | 64 | $698.00 | $512.40 | 73.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 34 | $3,740 | $1,884 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 21 | $3,570 | $1,272 | 35.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 48 | 60 | $600.00 | $172.46 | 28.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 35 | $5,360 | $3,122 | 58.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 37 | 39 | $390.00 | $114.00 | 29.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 28 | $3,780 | $1,297 | 34.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 27 | 27 | $270.00 | $74.51 | 27.6% |
About Marissa Harris, NP
Marissa Harris, NP is a Nurse Practitioner healthcare provider based in Ann Arbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2018. The National Provider Identifier (NPI) number assigned to this provider is 1508363961.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marissa Harris, NP has received a total of $7,689 in payments from pharmaceutical and medical device companies, with $919.94 received in 2024. These payments were reported across 421 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($7,514).
As a Medicare-enrolled provider, Harris has provided services to 325 Medicare beneficiaries, totaling 377 services with total Medicare billing of $12,620. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Ann Arbor, MI
- Active Since 04/11/2018
- Last Updated 06/25/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1508363961
Products in Payments
- XARELTO (Drug) $637.64
- Kerendia (Drug) $577.28
- Rybelsus (Drug) $466.35
- Ozempic (Drug) $399.03
- Otezla (Drug) $368.35
- TRELEGY ELLIPTA (Drug) $333.86
- MOUNJARO (Drug) $309.62
- JARDIANCE (Drug) $298.27
- VRAYLAR (Drug) $281.27
- FARXIGA (Drug) $258.41
- Dexcom G6 Transmitter (Medical Supply) $247.20
- VIBERZI (Drug) $224.60
- RYBELSUS (Drug) $176.31
- ELIQUIS (Drug) $176.11
- STIOLTO RESPIMAT (Drug) $171.73
- ENTRESTO (Drug) $150.11
- TRULICITY (Drug) $148.38
- Repatha (Biological) $143.36
- UBRELVY (Drug) $127.08
- EVENITY (Biological) $116.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Ann Arbor
Susanne Quallich, Np, NP
Nurse Practitioner — Payments: $36,229
Susanne Mc Devitt, Np, NP
Nurse Practitioner — Payments: $18,872
Joan Armstrong, N.p, N.P
Nurse Practitioner — Payments: $7,657
Christopher Naismith, Np, NP
Nurse Practitioner — Payments: $7,402
Eva Timbus, Np, NP
Nurse Practitioner — Payments: $5,101
Kimberly Dimaria, Np, NP
Nurse Practitioner — Payments: $4,502